Cargando…
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) has become one of the most common hematological diseases in western countries, with an annual incidence of 42/100,000. Conventional chemotherapy and targeted therapeutic drugs showed limitations in prognosis or in efficiency in high-risk patients. Immunotherapy rep...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107371/ https://www.ncbi.nlm.nih.gov/pubmed/37078002 http://dx.doi.org/10.3389/fonc.2022.1077436 |